http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02079470-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec4495c3fedc6f18c38c2f0fcb74d2fb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
filingDate 2002-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e1c30de3f940c107ef7712cf614e822
publicationDate 2002-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02079470-A1
titleOfInvention Disease-specific promoter chimeras for gene expression
abstract The present invention is directed to construction of novel gene delivery (expression) vectors and a method for producing disease-specific promoter chimeras sensitive to genotoxic stress by combining promoters, introns or other transcription regulatory sequences from disease-specific genes with viral gene promoter, intron or other transcription regulatory elements. The present invention also provides a method for producing chimeras of viral and cellular promoters, introns or other transcription regulatory sequences that have improved tissue-specific, targeting properties.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2008202914-B2
priorityDate 2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5968735-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5658759-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5688688-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5385839-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID499950
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466943124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129922365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23619366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396287
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395601

Total number of triples: 52.